FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045302557> ?p ?o ?g. }

• W2045302557 endingPage "63" @default.
• W2045302557 startingPage "53" @default.
• W2045302557 abstract "Objective To evaluate the glycemic effect of colesevelam, rosiglitazone, or sitagliptin when added to metformin monotherapy in patients with type 2 diabetes mellitus (DM) and to examine the effects of these antidiabetes agents on lipid and lipoprotein levels. Methods This 16-week, open-label pilot study conducted between May 2007 and April 2008 at 20 sites in the United States, 7 sites in Mexico, and 6 sites in Colombia, enrolled adults with inadequately controlled type 2 DM (glycated hemoglobin [HbA1c], 7.0%-10.0%) on a stable metformin regimen (1500-2550 mg daily for ≥3 months). At Week 0, participants were randomly assigned 1:1:1 to open-label colesevelam hydrochloride, 3.75 g daily; openlabel rosiglitazone maleate, 4 mg daily; or open-label sitagliptin phosphate, 100 mg daily, in addition to existing metformin therapy. The primary efficacy variable was the change in HbA1c from baseline to Week 16 with last (postbaseline) observation carried forward. Results In total, 169 participants were randomly assigned to treatment groups (colesevelam, n = 57; rosiglitazone, n = 56; and sitagliptin, n = 56), and 141 participants (83.4%) completed the study. Least-squares mean reductions in HbA1c from baseline were observed in all groups at Week 16 last observation carried forward (colesevelam, -0.3% [P<.031]; rosiglitazone: -0.6% [P<.001]; sitagliptin: -0.4% [P<.009]) At study end, 10 of 56 participants (17.9%) in the colesevelam group, 19 of 54 (35.2%) in the rosiglitazone group, and 15 of 55 (27.3%) in the sitagliptin group achieved HbA1c <7.0%. Colesevelam significantly reduced mean low-density lipoprotein (LDL)-cholesterol levels relative to baseline (11.6%), whereas levels were significantly increased with rosiglitazone and sitagliptin at Week 16 last observation carried forward (7.8% and 7.7%, respectively). Twenty-two of 52 participants (42.3%) in the colesevelam group, 12 of 51 (23.5%) in the rosiglitazone group, and 13 of 53 (24.5%) in the sitagliptin group achieved LDL cholesterol <100 mg/dL at Week 16 last observation carried forward. Conclusion All 3 antidiabetes agents significantly improved glycemic control, but only colesevelam also significantly reduced LDL-cholesterol levels in patients with type 2 DM. (Endocr Pract. 2010;16:53-63)" @default.
• W2045302557 created "2016-06-24" @default.
• W2045302557 creator A5017679504 @default.
• W2045302557 creator A5024129267 @default.
• W2045302557 creator A5037652425 @default.
• W2045302557 creator A5051375114 @default.
• W2045302557 creator A5087847578 @default.
• W2045302557 creator A5091096661 @default.
• W2045302557 date "2010-01-01" @default.
• W2045302557 modified "2023-09-23" @default.
• W2045302557 title "Effects of Colesevelam, Rosiglitazone, or Sitagliptin on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Metformin Monotherapy" @default.
• W2045302557 cites W1971627211 @default.
• W2045302557 cites W1972329806 @default.
• W2045302557 cites W2007003907 @default.
• W2045302557 cites W2040096459 @default.
• W2045302557 cites W2042129134 @default.
• W2045302557 cites W2046189497 @default.
• W2045302557 cites W2080848416 @default.
• W2045302557 cites W2101246901 @default.
• W2045302557 cites W2130813021 @default.
• W2045302557 cites W2138109132 @default.
• W2045302557 cites W2139611060 @default.
• W2045302557 cites W2153449155 @default.
• W2045302557 cites W2169775081 @default.
• W2045302557 cites W2170271198 @default.
• W2045302557 cites W2171294019 @default.
• W2045302557 cites W2171512247 @default.
• W2045302557 cites W2626017884 @default.
• W2045302557 doi "https://doi.org/10.4158/ep09146.or" @default.
• W2045302557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19789153" @default.
• W2045302557 hasPublicationYear "2010" @default.
• W2045302557 type Work @default.
• W2045302557 sameAs 2045302557 @default.
• W2045302557 citedByCount "38" @default.
• W2045302557 countsByYear W20453025572012 @default.
• W2045302557 countsByYear W20453025572013 @default.
• W2045302557 countsByYear W20453025572014 @default.
• W2045302557 countsByYear W20453025572015 @default.
• W2045302557 countsByYear W20453025572017 @default.
• W2045302557 countsByYear W20453025572020 @default.
• W2045302557 countsByYear W20453025572021 @default.
• W2045302557 crossrefType "journal-article" @default.
• W2045302557 hasAuthorship W2045302557A5017679504 @default.
• W2045302557 hasAuthorship W2045302557A5024129267 @default.
• W2045302557 hasAuthorship W2045302557A5037652425 @default.
• W2045302557 hasAuthorship W2045302557A5051375114 @default.
• W2045302557 hasAuthorship W2045302557A5087847578 @default.
• W2045302557 hasAuthorship W2045302557A5091096661 @default.
• W2045302557 hasConcept C126322002 @default.
• W2045302557 hasConcept C134018914 @default.
• W2045302557 hasConcept C2776923340 @default.
• W2045302557 hasConcept C2777180221 @default.
• W2045302557 hasConcept C2777538456 @default.
• W2045302557 hasConcept C2779284873 @default.
• W2045302557 hasConcept C2780152017 @default.
• W2045302557 hasConcept C2780323712 @default.
• W2045302557 hasConcept C2780473172 @default.
• W2045302557 hasConcept C2781413609 @default.
• W2045302557 hasConcept C2910068830 @default.
• W2045302557 hasConcept C2910260750 @default.
• W2045302557 hasConcept C555293320 @default.
• W2045302557 hasConcept C71924100 @default.
• W2045302557 hasConcept C90924648 @default.
• W2045302557 hasConceptScore W2045302557C126322002 @default.
• W2045302557 hasConceptScore W2045302557C134018914 @default.
• W2045302557 hasConceptScore W2045302557C2776923340 @default.
• W2045302557 hasConceptScore W2045302557C2777180221 @default.
• W2045302557 hasConceptScore W2045302557C2777538456 @default.
• W2045302557 hasConceptScore W2045302557C2779284873 @default.
• W2045302557 hasConceptScore W2045302557C2780152017 @default.
• W2045302557 hasConceptScore W2045302557C2780323712 @default.
• W2045302557 hasConceptScore W2045302557C2780473172 @default.
• W2045302557 hasConceptScore W2045302557C2781413609 @default.
• W2045302557 hasConceptScore W2045302557C2910068830 @default.
• W2045302557 hasConceptScore W2045302557C2910260750 @default.
• W2045302557 hasConceptScore W2045302557C555293320 @default.
• W2045302557 hasConceptScore W2045302557C71924100 @default.
• W2045302557 hasConceptScore W2045302557C90924648 @default.
• W2045302557 hasIssue "1" @default.
• W2045302557 hasLocation W20453025571 @default.
• W2045302557 hasOpenAccess W2045302557 @default.
• W2045302557 hasPrimaryLocation W20453025571 @default.
• W2045302557 hasRelatedWork W1538553036 @default.
• W2045302557 hasRelatedWork W1987248351 @default.
• W2045302557 hasRelatedWork W2035838062 @default.
• W2045302557 hasRelatedWork W2045302557 @default.
• W2045302557 hasRelatedWork W2047379913 @default.
• W2045302557 hasRelatedWork W2097893376 @default.
• W2045302557 hasRelatedWork W2099092932 @default.
• W2045302557 hasRelatedWork W2944494854 @default.
• W2045302557 hasRelatedWork W3016463962 @default.
• W2045302557 hasRelatedWork W2496840989 @default.
• W2045302557 hasVolume "16" @default.
• W2045302557 isParatext "false" @default.
• W2045302557 isRetracted "false" @default.
• W2045302557 magId "2045302557" @default.
• W2045302557 workType "article" @default.